Paul Darling is a Principal with ZS Associates in the firm’s San Francisco office.  Paul assists life sciences companies in evaluating new markets, acquisitions, and licensing opportunities as well as developing the associated go-to-market strategies.  He has presented at several industry conferences on the topics of forecasting, asset valuation, and alliance structuring. 

Paul developed and leads ZS's Institute on U.S. Healthcare Evolution and Scenario Planning.  He is currently exploring opportunities for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform, including new business models, therapies, acquisitions, and partnerships, as well as reimagining the commercial model to support such portfolio changes.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in Statistical Thermodynamics from Washington University.